NEW YORK, Feb. 4 (GenomeWeb News) - Axygen Scientific has created a new subdivision called Axygen Bioscience that focuses on genomics, proteomics, and protein crystallography.
The company decided to create the new division in order to expand into the area of proteomics, which executives identified as one of the key areas for pharmaceutical companies, Arezou Arazani, director of new product and business development at Axygen Bioscience, told GenomeWeb News.
"They brought me into the company and said they wanted to get into new technology," said Arazani. "I said the future is in proteomics. Most pharma companies have genetic information from humans and other species, but they need the protein for more information. The new technology covers all the area from DNA to protein crystallography."
Products produced by the new division include nucleic acid and peptide purification kits, markers, crystallography plates, sealers, reagents, software, databases, and high-throughput laboratory robotics and automation platforms.